Cohen S, Williamson G Psychological stress in a probability sample of the United States. In: Spacapan S, Oskamp S, eds. The social psychology of health. Newbury Park, CA: Sage; 1988:31-67.
Crane M Why burned-out doctors get sued more often. Med Econ. 1998 May 26;75(10):210-2, 215-8.
Dunn PM, Arnetz BB, Christensen JF, Homer L Meeting the imperative to improve physician well-being: assessment of an innovative program. J Gen Intern Med. 2007 Nov;22(11):1544-52. Epub 2007 Sep 22.
Fujimori M, Shirai Y, Asai M, Akizuki N, Katsumata N, Kubota K, Uchitomi Y Development and preliminary evaluation of communication skills training program for oncologists based on patient preferences for communicating bad news. Palliat Support Care. 2014 Oct;12(5):379-86. doi: 10.1017/S147895151300031X. Epub 2013 Nov 4.
Goodman MJ, Schorling JB A mindfulness course decreases burnout and improves well-being among healthcare providers. Int J Psychiatry Med. 2012;43(2):119-28.
Hojat M, Mangione S, Nasca T, et al The Jefferson Scale of Physician Empathy: Development and Preliminary Psychometric Data. Educ Psychol Meas. 2001; 61(2):349-365.
International Wellbeing Group Personal Wellbeing Index: 5th edition. Melbourne: Australian Centre on Quality of Life, Deakin University; 2013.
O'Connor PG, Spickard A Jr Physician impairment by substance abuse. Med Clin North Am. 1997 Jul;81(4):1037-52. Review.
Ospina-Kammerer V, Figley CR An evaluation of the Respiratory One Method (ROM) in reducing emotional exhaustion among family physician residents. Int J Emerg Ment Health. 2003 Winter;5(1):29-32.
Rosdahl JA, Kingsolver KO Mindfulness training to increase resilience and decrease stress and burnout in ophthalmology residents: A pilot study. Invest Ophthalmol Vis Sci. 2014;55(13):5579.
Shanafelt TD, Hasan O, Dyrbye LN, Sinsky C, Satele D, Sloan J, West CP Changes in Burnout and Satisfaction With Work-Life Balance in Physicians and the General US Working Population Between 2011 and 2014. Mayo Clin Proc. 2015 Dec;90(12):1600-13. doi: 10.1016/j.mayocp.2015.08.023. Erratum in: Mayo Clin Proc. 2016 Feb;91(2):276.
Shanafelt TD, Noseworthy JH Executive Leadership and Physician Well-being: Nine Organizational Strategies to Promote Engagement and Reduce Burnout. Mayo Clin Proc. 2017 Jan;92(1):129-146. doi: 10.1016/j.mayocp.2016.10.004. Epub 2016 Nov 18. Review.
Thomas NK Resident burnout. JAMA. 2004 Dec 15;292(23):2880-9. Review.
Wallace JE, Lemaire JB, Ghali WA Physician wellness: a missing quality indicator. Lancet. 2009 Nov 14;374(9702):1714-21. doi: 10.1016/S0140-6736(09)61424-0. Review.
West CP, Dyrbye LN, Erwin PJ, Shanafelt TD Interventions to prevent and reduce physician burnout: a systematic review and meta-analysis. Lancet. 2016 Nov 5;388(10057):2272-2281. doi: 10.1016/S0140-6736(16)31279-X. Epub 2016 Sep 28. Review.
Winefield H, Farmer E, Denson L Work stress management for women general practitioners: An evaluation. Psychol Health Med. 1998;3(2):163-170.
Building Physician Resiliency Through CREATION Health: A Research Study
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
